Commission cites evidence it alleges shows that Shkreli repeatedly violated a 2022 order that banned him from working in the pharmaceutical industry for life The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry.View Press Release
{
"category": null,
"company_link_version": "company-mentions-v2",
"company_mentions": [],
"coverage": "official RSS press release; short feed summary only",
"language": "en",
"published_at": "2026-10-13T12:00:00Z",
"source": "ftc-press",
"summary": "Commission cites evidence it alleges shows that Shkreli repeatedly violated a 2022 order that banned him from working in the pharmaceutical industry for life The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry.View Press Release",
"title": "FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry",
"url": "https://www.ftc.gov/news-events/news/press-releases/2026/10/ftc-states-ask-federal-court-hold-martin-shkreli-contempt-allegedly-violating-lifetime"
}
Evidence-based analysis
facts, provenance and explicit model coverage
Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.
Dimension
Status / value
Method or boundary
What happened
available · FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry
Commission cites evidence it alleges shows that Shkreli repeatedly violated a 2022 order that banned him from working in the pharmaceutical industry for life The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry.View Press Release
When
source_backed · reported 2026-10-13
Occurred 2026-10-13. Source-record timestamps; no timezone or event time is inferred.
Affected entities
resolved · Federal Trade Commission · 0 related
Canonical primary entity and stored related_entity_ids only.
Event classification
news · news.press_release
canonical event type plus source-provided category; no sentiment or impact is inferred
Entity linking
resolved
Canonical entity resolved during ingestion
Deduplication
applied
unique source event key at ingestion
Source trust
high · terms allowed
Source registry metadata
Sentiment
not_covered
No sentiment model output is published for this record.
Market reaction
not_covered
Requires licensed quote, candle and volume observations for the affected instrument.
Historical analogs
not_covered
Requires an audited event-cluster corpus and matching methodology.
Impact mechanism
not_covered
No causal market-impact model is published for this record.
Related risks
not_covered
Risk implications require an audited instrument/entity exposure model.
Instrument linkage
not_covered
No instrument relation is inferred from an entity event; licensed instrument mapping is required.
We use essential cookies for sign-in, security and saved features. Recent-search history and performance analytics are optional and off until you choose.
Read our privacy policy ↗FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry — recorded event — investment.com